Delayed-type hypersensitivity and chronic fatigue syndrome: the usefulness of assessing T-cell activation by flow cytometry--preliminary study. — CFSMEATLAS
Delayed-type hypersensitivity and chronic fatigue syndrome: the usefulness of assessing T-cell activation by flow cytometry--preliminary study.
Brunet, J L, Liaudet, A P, Later, R et al. · Allergie et immunologie · 2001
Quick Summary
This small study looked at whether people with ME/CFS have exaggerated immune reactions to common substances like yeast (Candida). Researchers tested this by applying yeast extract under the skin and watching for delayed reactions, then measuring immune cell activity in blood samples. About half of the ME/CFS patients showed these exaggerated reactions, suggesting the immune system may be responding unusually to everyday germs.
Why It Matters
This research provides objective immunological markers that could help identify a subset of ME/CFS patients with specific immune dysfunction, potentially opening pathways for targeted therapeutic approaches. Understanding whether abnormal hypersensitivity responses contribute to ME/CFS pathophysiology could shift treatment paradigms from purely symptomatic management.
Observed Findings
Approximately 50% of ME/CFS patients showed delayed-type hypersensitive responses to Candida albicans antigens.
Intensity of skin test reactions correlated with in vitro T-cell activation measured by flow cytometry.
T-cell activation was detected using CD3, CD4, and activation markers (CD69 or CD25).
Inferred Conclusions
Some ME/CFS patients may have dysregulated delayed-type hypersensitivity responses to common commensal organisms.
Cellular immune activation detectable in vitro correlates with clinical DTH responses in skin tests.
A multifactorial approach combining immunological testing may better characterize immune dysfunction in ME/CFS subgroups.
Remaining Questions
Is this hypersensitivity pattern specific to ME/CFS or present in other fatiguing illnesses?
Does this immune dysregulation play a causal role in fatigue symptomatology, or is it an epiphenomenon?
What proportion of the broader ME/CFS population exhibits this phenotype, and are there clinical or molecular characteristics that identify responders?
What This Study Does Not Prove
This study does not prove that hypersensitivity to Candida or environmental antigens causes ME/CFS fatigue. The lack of a control group, small sample size, and preliminary nature mean these findings cannot establish causality or demonstrate that this immune pattern is specific to ME/CFS rather than other conditions. Correlation between skin test intensity and T-cell activation does not explain the mechanism of fatigue itself.